Simplifying access to antivirals for hepatitis C patients may be possible with serum tests of fibrosis such as FIB-4 that can exclude cirrhosis in settings without access to transient elastography, Australian research shows. Dr Lauren Burrage, a registrar, and colleagues at the Sunshine Coast University Hospital have shown the FIB-4 test, at a cut-off of ...
Serum based fibrosis tests could obviate need for elastography prior to DAAs
By Mardi Chapman
6 Feb 2020